Reymond M J, Porter J C
Endocrinology. 1982 Oct;111(4):1051-6. doi: 10.1210/endo-111-4-1051.
An accumulation of L-dihydroxyphenylalanine (DOPA) in the median eminence of female rats treated with 3-hydroxybenzylhydrazine (NSD 1015), and inhibitor of aromatic L-amino acid decarboxylase (DOPA decarboxylase) activity, was associated with a decreased concentration of dopamine in the median eminence and pronounced reduction in the release of dopamine into hypophysial portal blood. The amount of dopamine released during 1 h into hypophysial portal blood of vehicle-treated rats represented 18% of the amount of DOPA that accumulated in 1 h in the median eminence of rats treated with NSD 1015. The reduction in the concentration of dopamine in the plasma of blood from a single hypophysial portal vessel after the inhibition of DOPA decarboxylase activity was associated with a concomitant increase in the concentration of PRL in the plasma of arterial blood. In contrast to that of dopamine, the concentration of norepinephrine as well as the concentration of epinephrine in hypophysial portal plasma was the same or slightly greater in animals treated with NSD 1015 than in animals treated with the solvent vehicle. These findings are supportive of the view that the release of dopamine from the tuberoinfundibular neurons is highly dependent on the rate of conversion of DOPA to dopamine and that the rate of synthesis of DOPA is a major factor in the control of the rate of release of dopamine into hypophysial portal blood.
用芳香族L-氨基酸脱羧酶(多巴脱羧酶)活性抑制剂3-羟基苄基肼(NSD 1015)处理的雌性大鼠,其正中隆起中L-二羟基苯丙氨酸(DOPA)的积累,与正中隆起中多巴胺浓度降低以及多巴胺释放到垂体门脉血中的显著减少有关。在1小时内,未处理大鼠垂体门脉血中释放的多巴胺量占NSD 1015处理大鼠正中隆起中1小时内积累的DOPA量的18%。抑制多巴脱羧酶活性后,单个垂体门脉血管血液中血浆多巴胺浓度降低,同时动脉血血浆中催乳素(PRL)浓度升高。与多巴胺不同,NSD 1015处理的动物垂体门脉血浆中去甲肾上腺素浓度以及肾上腺素浓度与溶剂处理的动物相同或略高。这些发现支持了以下观点:来自结节漏斗神经元的多巴胺释放高度依赖于DOPA向多巴胺的转化速率,并且DOPA的合成速率是控制多巴胺释放到垂体门脉血中的速率的主要因素。